ticket’s chance that their disease might not even be a
of these options, we won’t have to worry about the costs.
This iswhy theRword—“rationing”—remainssuch a
potent charge. There is broad unease with the
circumstances we’ve found ourselves in but fear of
end to strategy—the case of Nelene Fox.
with metastatic breast cancer in 1991, when she was
thirty-eight years old. Surgery and conventional
marrow. The disease was terminal. Doctors at the
Universityof Southern Californiaofferedher aradical
but seemingly promising new treatment—high-dose
it was her one chance of cure.
excluded under the terms of her policy. The insurer